BioSpace News Archive

Business

Quoin Pharmaceuticals Announces Second Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday August 3rd at 8:30 am ET

Quoin Pharmaceuticals Ltd. announced today that the Company plans to release its second quarter 2023 financial results after the market closes on Wednesday, August 2, 2023.

July 27, 2023
·
1 min read
Business

Integer Holdings Corporation Reports Second Quarter 2023 Results

Integer Holdings Corporation, a leading medical device outsource manufacturer, announced results for the three months ended June 30, 2023.

July 27, 2023
·
26 min read
BioMidwest

Horizon Therapeutics plc Announces 2023 #RAREis Global Advocate Grant Recipients

Horizon Therapeutics plc announced the 50 awardees from around the world selected to receive the 2023 #RAREis™ Global Advocate Grant.

July 27, 2023
·
4 min read
Deals

ABVC BioPharma Announces Pricing of $1.75 Million Registered Direct Offering

ABVC BioPharma, Inc. today announced it has entered into a definitive securities purchase agreement with a single institutional investor to purchase $1.75 million worth of its common stock in a registered direct offering (the “Offering”).

July 27, 2023
·
5 min read
Business

Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results

Accelerate Diagnostics, Inc. announced that management will host a conference call on Thursday, August 10, 2023, at 4:30 p.m. Eastern Time to review 2023 second quarter results.

July 27, 2023
·
1 min read
Business

Co-Diagnostics, Inc. Announces Second Quarter 2023 Earnings Release Date and Webcast

Co-Diagnostics, Inc. announced today it will release its second quarter 2023 results on Thursday, August 10, 2023, after the market close.

July 27, 2023
·
1 min read
Drug Development

UGN-102, in Development as the Potential First Non-Surgical Therapy for LG-IR-NMIBC, Met Primary Endpoints in Both Phase 3 ATLAS and ENVISION Clinical Trials

UroGen Pharma Ltd. (Nasdaq: URGN) today announced positive topline data from its Phase 3 trials ATLAS and ENVISION studying UGN-102 (mitomycin) for intravesical solution in patients with low-grade, intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

July 27, 2023
·
9 min read
Pharm Country

TriRx Partnership with Liverpool City Region Advances Biotech Capabilities

TriRx Pharmaceutical Services, LLC, a Contract Development and Manufacturing Organization, welcomed the UK Government’s recent announcement on England’s second Investment Zone, focused on Life Sciences in the Liverpool City Region.

July 27, 2023
·
2 min read
icotec ag Announces FDA 510(k) Clearance for VADER® Pedicle System Navigated Instruments, Advancing Precision and Safety in Spinal Implantation

icotec, a leading medical device manufacturer specializing in BlackArmor® Carbon/PEEK spinal implants, is pleased to announce the receipt of FDA 510(k) clearance for its VADER® Pedicle System Navigated Instruments.

July 27, 2023
·
2 min read
Genetown

Filspari and Tarpeyo launches off to a great start in IgAN (MARKETVUE® REPORT)

IgA nephropathy is an autoimmune glomerular disease and leading cause of chronic kidney disease.

July 27, 2023
·
2 min read